|
|
Examining the Number of Competitors and the Cost of Medicare Part D: Working Paper 2014-04Working Paper
CBO releases a companion working paper to its report Competition and the Cost of Medicare’s Prescription Drug Program.     Competition and the Cost of Medicare’s Prescription Drug ProgramReport
Why has Medicare's prescription drug program cost less than anticipated when the program was created? How has competition between plan sponsors affected spending? How do Medicare Part D drug prices compare to those in Medicaid? |
